Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Quality Measurement Improves Rheumatology Outcomes

Kathleen Louden  |  Issue: January 2012  |  January 13, 2012

“Of those I interviewed, many providers said if the patient was on glucocorticoids more than three months or more than six months, they would be more likely to give a coprescription.”

Dr. Kohler called for more education of primary-care providers regarding this important recommendation.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

 

Rheumatology Data Collection

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
Dr. Newman

Dr. Newman

Electronic health records do not provide all the information that rheumatologists need, contends Eric D. Newman, MD, director of rheumatology at Geisinger Medical Center in Danville, Pa. Therefore, he and his coworkers designed and studied implementation of a visual display software program that allowed them to collect the objective information they need (see Figure 1). Called Rheum-PACER (for Patient-Centric Electronic Redesign), the web-based software uses a touchscreen questionnaire to collect information, such as demographics, from patients. An instant nurse messaging system—a novel feature, according to Dr. Newman—allows nurses to track the patient’s progress and assist if needed. The software assembles the information from the patient, nurse, physician, and health record.

When the physician examines the patient and enters data, such as symptoms and disease activity, into the program, the software gives results in real time. It also creates a clinic note and moves it into the electronic medical record, and allows printing of an after-visit summary for the patient. A two-year study showed an 86% adoption rate of the software among physicians, said Dr. Newman. More than 1,400 patients with RA participated in the study. For those patient visits, the new program significantly increased provider productivity, measured by relative value units, and net revenue rose by 26% for each visit (P =.03 each).

The software is not yet commercially available, said Dr. Newman. Other presentations included using electronic health records to generate run charts that help monitor performance in treating various rheumatologic diseases at Cincinnati Children’s Hospital. A quality-improvement project from Nationwide Children’s Hospital in Columbus, Ohio, also improved the electronic patient record. To increase the influenza vaccination rates in pediatric rheumatology clinics, the researchers added a best-practice alert about vaccination that providers saw on a pop-up screen whenever they signed orders. The investigators reportedly more than tripled the rate of influenza immunization in two years.

 

click for large version
Figure 1: Sample outcomes page view of RheumPACER software.

Projects Target ACR Priorities

Session comoderator Jinoos Yazdany, MD, MPH, assistant professor of medicine at the University of California, San Francisco, and a member of the ACR Quality Measurement White Paper Development Workgroup, told The Rheumatologist she was excited that the researchers applied to their real-world settings some of the quality measures that the ACR has endorsed. “At this session, we saw rheumatologists applying data and innovations in health information technology to drive quality improvement at their institutions, with significant impact,” she said. “It is very likely that some of the successful measures-development and implementation projects performed by rheumatologists in their own communities will help inform what we do at the ACR at the national level.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsDrug UpdatesInformation TechnologyMeeting ReportsOsteoarthritis and Bone DisordersPractice SupportQuality Assurance/ImprovementResearch RheumTechnologyTechnology Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)drugGlucocorticoidsOsteoporosispatient carePractice ManagementQualityRAResearchRheumatoid arthritisrheumatologistSafetyTechnology

Related Articles
    Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges

    Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges

    June 15, 2017

    Rheumatologists treating HIV patients in 2017 must think through many important factors as this population ages. As we continue to learn, rheumatologists must consider important drug–drug interactions, relatively uncommon rheumatological presentations of HIV, as well as specific diagnostic challenges. Working closely with infectious disease specialists is the best way to achieve optimum care for this…

    Higher Risk of Adverse Events When Biologic Infusions Are Done at Home

    June 15, 2021

    (Reuters Health)—Patients who receive biologic infusions at home may have a higher risk of adverse events than those who receive the infusions at a health care facility, a new study suggests.1 Researchers examined administrative claims data on 57,220 adults who received a total of 752,150 biologic infusions for immune-mediated disease between 2007 and 2017. The…

    Behind the Digital Door

    April 13, 2011

    Rheumatology practices work toward becoming “meaningful users” of EHRs

    2013 ACR/ARHP Annual Meeting: New Tools to Measure Quality in Rheumatology

    January 1, 2014

    Rising healthcare costs, shifting market forces will require rheumatologists to adapt new quality measurement techniques, more effective patient care models, better rheumatology registries

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences